Literature DB >> 23034018

France's new framework for regulating off-label drug use.

Joseph Emmerich1, Nathalie Dumarcet, Annie Lorence.   

Abstract

Mesh：

Year:  2012        PMID： 23034018     DOI： 10.1056/NEJMp1208347

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  Market access of cancer drugs in European countries: improving resource allocation.

Authors:  Kim Pauwels; Isabelle Huys; Minne Casteels; Katelijne De Nys; Steven Simoens
Journal:  Target Oncol       Date:  2013-11-19       Impact factor: 4.493

2.  Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?

Authors:  Roojin Habibi; Joel Lexchin; Barbara Mintzes; Anne Holbrook
Journal:  Br J Clin Pharmacol       Date:  2017-08-19       Impact factor: 4.335

3.  Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities.

Authors:  Sandeep Kumar Gupta; Roopa Prasad Nayak
Journal:  J Pharmacol Pharmacother       Date:  2014-04

4.  Off-label drug prescriptions in French general practice: a cross-sectional study.

Authors:  François Drogou; Allison Netboute; Joris Giai; Xavier Dode; David Darmon; Behrouz Kassai; Laurent Letrilliart
Journal:  BMJ Open       Date:  2019-04-09       Impact factor: 2.692

5.  Current practice and awareness of pediatric off-label drug use in Shanghai, China -a questionnaire-based study.

Authors:  Mei Mei; Hong Xu; Libo Wang; Guoying Huang; Yonghao Gui; Xiaobo Zhang
Journal:  BMC Pediatr       Date:  2019-08-13       Impact factor: 2.125

Review 6.  Bevacizumab for eye diseases - Legal, regulatory, and ethical overview.

Authors:  Vinu Jose; Swetha Radhakrishna; Parag Pipalava; Inderjeet Singh
Journal:  Indian J Pharmacol       Date:  2020-01-16       Impact factor: 1.200

7.  Malpractice in radiology: what should you worry about?

Authors:  Alessandro Cannavale; Mariangela Santoni; Paola Mancarella; Roberto Passariello; Paolo Arbarello
Journal:  Radiol Res Pract       Date:  2013-04-03

Review 8.  Regulating off-label drug use in India: The arena for concern.

Authors:  Sukhvinder Singh Oberoi
Journal:  Perspect Clin Res       Date:  2015 Jul-Sep

9.  Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey.

Authors:  Benjamin Rolland; François Paille; Benoit Fleury; Olivier Cottencin; Amine Benyamina; Henri-Jean Aubin
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

Review 10.  Ethical and legal framework and regulation for off-label use: European perspective.

Authors:  Christian Lenk; Gunnar Duttge
Journal:  Ther Clin Risk Manag       Date:  2014-07-12       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.